PREVALENCE OF HEPATIC STEATOSIS AMONG CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS AND ITS ASSOCIATION WITH NUTRITIONAL STATUS

Overview

Journal Rev Paul Pediatr

Specialty Pediatrics

Date 2019 Jun 27

PMID 31241693

Authors

Amanda Oliva Gobato

Ana Carolina Junqueira Vasques

Antonio Fernando Ribeiro

Roberto Massao Yamada

Gabriel Hessel

Affiliations

Soon will be listed here.

Abstract

Objective: To determine the prevalence of hepatic steatosis (HS) in children and adolescents with cystic fibrosis (CF) and associate it with nutritional status.

Methods: Cross-sectional study with children and adolescents with CF diagnosis. Weight and height were used to calculate the body mass index (BMI) and subsequent classification of the nutritional status. The midarm circumference (MAC), triceps skinfold thickness (TSF) and midarm muscle circumference (MAMC) were used to evaluate body composition. Abdominal ultrasonography was performed for diagnosis of HS. The statistical tests used were Student's t test, Mann-Whitney test and chi-square test with significance level of 5%.

Results: 50 patients with CF were evaluated, 18 (36%) were diagnosed with HS (Group A) and 32 (64%) without HS (Group B). The mean age of Group A was 13,2±4,9 years old and Group B 11,7±4,9; for BMI, the value for Group A was 18,0±4,1 and Group B was 15,7±3,8; the TSF of Group A was 8,4±3,5 mm and Group B was 7,0±2,5 mm. For these variables, there was no significant difference between the groups. The mean of MAC and MAMC differed significantly between the groups, being higher in the HS group, with p values of 0,047 and 0,043.

Conclusions: The frequency of HS in patients with CF is high and it is not related to malnutrition, according to the parameters of BMI, TSF and MAMC. The values of MAC and MAMC indicated a greater reserve of muscle mass in patients with HS.

References

Colombo C, Battezzati P . Liver involvement in cystic fibrosis: primary organ damage or innocent bystander?. J Hepatol. 2004; 41(6):1041-4. DOI: 10.1016/j.jhep.2004.10.002. View

Feranchak A, Sokol R . Cholangiocyte biology and cystic fibrosis liver disease. Semin Liver Dis. 2001; 21(4):471-88. DOI: 10.1055/s-2001-19030. View

Herrmann U, Dockter G, Lammert F . Cystic fibrosis-associated liver disease. Best Pract Res Clin Gastroenterol. 2010; 24(5):585-92. DOI: 10.1016/j.bpg.2010.08.003. View

Moran A, Pillay K, Becker D, Acerini C . ISPAD Clinical Practice Consensus Guidelines 2014. Management of cystic fibrosis-related diabetes in children and adolescents. Pediatr Diabetes. 2014; 15 Suppl 20:65-76. DOI: 10.1111/pedi.12178. View

Ayoub F, Trillo-Alvarez C, Morelli G, Lascano J . Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease. World J Hepatol. 2018; 10(1):34-40. PMC: 5787682. DOI: 10.4254/wjh.v10.i1.34. View

Rowland M, Gallagher C, OLaoide R, Canny G, Broderick A, Hayes R . Outcome in cystic fibrosis liver disease. Am J Gastroenterol. 2010; 106(1):104-9. DOI: 10.1038/ajg.2010.316. View

Angulo P, Lindor K . Non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2002; 17 Suppl:S186-90. DOI: 10.1046/j.1440-1746.17.s1.10.x. View

Kobelska-Dubiel N, Klincewicz B, Cichy W . Liver disease in cystic fibrosis. Prz Gastroenterol. 2014; 9(3):136-41. PMC: 4110359. DOI: 10.5114/pg.2014.43574. View

Joseph A, Saverymuttu S, Al-Sam S, Cook M, Maxwell J . Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol. 1991; 43(1):26-31. DOI: 10.1016/s0009-9260(05)80350-2. View

10.

Osawa H, Mori Y . Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes. J Clin Ultrasound. 1996; 24(1):25-9. DOI: 10.1002/(SICI)1097-0096(199601)24:1<25::AID-JCU4>3.0.CO;2-N. View

11.

Maqbool A, Schall J, Gallagher P, Zemel B, Strandvik B, Stallings V . Relation between dietary fat intake type and serum fatty acid status in children with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2012; 55(5):605-11. PMC: 4699309. DOI: 10.1097/MPG.0b013e3182618f33. View

12.

Frisancho A . New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr. 1981; 34(11):2540-5. DOI: 10.1093/ajcn/34.11.2540. View

13.

van Zutphen T, Ciapaite J, Bloks V, Ackereley C, Gerding A, Jurdzinski A . Malnutrition-associated liver steatosis and ATP depletion is caused by peroxisomal and mitochondrial dysfunction. J Hepatol. 2016; 65(6):1198-1208. DOI: 10.1016/j.jhep.2016.05.046. View

14.

Pinto I, da Silva C, Britto M . Nutritional, clinical and socioeconomic profile of patients with cystic fibrosis treated at a referral center in northeastern Brazil. J Bras Pneumol. 2009; 35(2):137-43. DOI: 10.1590/s1806-37132009000200006. View

15.

OSullivan B, Freedman S . Cystic fibrosis. Lancet. 2009; 373(9678):1891-904. DOI: 10.1016/S0140-6736(09)60327-5. View

16.

Athanazio R, Silva Filho L, Vergara A, Ribeiro A, Riedi C, Procianoy E . Brazilian guidelines for the diagnosis and treatment of cystic fibrosis. J Bras Pneumol. 2017; 43(3):219-245. PMC: 5687954. DOI: 10.1590/S1806-37562017000000065. View

17.

Colombo C, Battezzati P, Crosignani A, Morabito A, Costantini D, Padoan R . Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome. Hepatology. 2002; 36(6):1374-82. DOI: 10.1053/jhep.2002.37136. View

18.

Staufer K, Halilbasic E, Trauner M, Kazemi-Shirazi L . Cystic fibrosis related liver disease--another black box in hepatology. Int J Mol Sci. 2014; 15(8):13529-49. PMC: 4159809. DOI: 10.3390/ijms150813529. View

19.

Gaskin K . Nutritional care in children with cystic fibrosis: are our patients becoming better?. Eur J Clin Nutr. 2013; 67(5):558-64. DOI: 10.1038/ejcn.2013.20. View

20.

Fustik S, Trajkovska M, Jakovska T, Spirevska L, Josifovska T, Koceva S . Screening for liver disease in cystic fibrosis: analysis of clinical and genetic risk factors for its development. Turk J Pediatr. 2009; 50(6):526-32. View